rhPRG4 has shown success in preserving joint health in vivo in osteoarthritis models, and a recent study demonstrated that it can also suppress transforming growth factor beta (TGFβ)-induced migration and invasion in breast cancer cells by reducing CD44 protein levels [145,146]. Here, CD44 is linked to breast carcinoma.